Alison M. Bendele

3.9k total citations
63 papers, 3.0k citations indexed

About

Alison M. Bendele is a scholar working on Rheumatology, Surgery and Molecular Biology. According to data from OpenAlex, Alison M. Bendele has authored 63 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 16 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Alison M. Bendele's work include Osteoarthritis Treatment and Mechanisms (22 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Tendon Structure and Treatment (7 papers). Alison M. Bendele is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (22 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Tendon Structure and Treatment (7 papers). Alison M. Bendele collaborates with scholars based in United States, Netherlands and Germany. Alison M. Bendele's co-authors include Gina Sennello, Elizabeth A. Chlipala, Molly A. Taylor, Christina L. Roark, Jena D. French, Willi K. Born, Rebecca L. O’Brien, George M. Shopp, Carl K. Edwards and Wim B. van den Berg and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Alison M. Bendele

61 papers receiving 2.9k citations

Peers

Alison M. Bendele
J M Dayer Switzerland
Andrew D. Cook Australia
A.M. Bendele United States
Anwen S. Williams United Kingdom
Alison M. Bendele
Citations per year, relative to Alison M. Bendele Alison M. Bendele (= 1×) peers Yuji Shirakata

Countries citing papers authored by Alison M. Bendele

Since Specialization
Citations

This map shows the geographic impact of Alison M. Bendele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Bendele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Bendele more than expected).

Fields of papers citing papers by Alison M. Bendele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison M. Bendele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Bendele. The network helps show where Alison M. Bendele may publish in the future.

Co-authorship network of co-authors of Alison M. Bendele

This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Bendele. A scholar is included among the top collaborators of Alison M. Bendele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Bendele. Alison M. Bendele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindström, Erik, Karin Tunblad, Charlotte Edenius, et al.. (2018). The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis. Journal of Translational Medicine. 16(1). 56–56. 50 indexed citations
2.
Wathier, Michel, Benjamin A. Lakin, Benjamin G. Cooper, et al.. (2018). A synthetic polymeric biolubricant imparts chondroprotection in a rat meniscal tear model. Biomaterials. 182. 13–20. 24 indexed citations
3.
Chandrasekhar, Srinivasan, Anita K. Harvey, J.L. Oskins, et al.. (2017). Analgesic and anti‐inflammatory properties of novel, selective, and potent EP4 receptor antagonists. Pharmacology Research & Perspectives. 5(3). e00316–e00316. 15 indexed citations
4.
Jahagirdar, Ravi, Sarah Attwell, Suzana Marušić, et al.. (2017). RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease. Molecular Pharmacology. 92(6). 694–706. 48 indexed citations
5.
LaBranche, Timothy P., Alison M. Bendele, Kathryn E. Gropp, et al.. (2016). Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model. Annals of the Rheumatic Diseases. 76(1). 295–302. 44 indexed citations
6.
Piraino, Susan, Patricia Berthelette, Alison M. Bendele, et al.. (2015). Overexpression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis. Arthritis Research & Therapy. 17(1). 5–5. 6 indexed citations
8.
Bendele, Alison M., et al.. (2012). Dose–response effect of an intra‐tendon application of recombinant human platelet‐derived growth factor‐BB (rhPDGF‐BB) in a rat Achilles tendinopathy model. Journal of Orthopaedic Research®. 31(3). 413–420. 32 indexed citations
9.
Flannery, Carl R., Richard Zollner, Chris Corcoran, et al.. (2009). Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis & Rheumatism. 60(3). 840–847. 184 indexed citations
10.
Roark, Christina L., Jena D. French, Molly A. Taylor, et al.. (2007). Exacerbation of Collagen-Induced Arthritis by Oligoclonal, IL-17-Producing γδ T Cells. The Journal of Immunology. 179(8). 5576–5583. 254 indexed citations
11.
Trumble, Troy N., R. Clark Billinghurst, Alison M. Bendele, & C. Wayne McIlwraith. (2005). Evaluation of changes in vertical ground reaction forces as indicators of meniscal damage after transection of the cranial cruciate ligament in dogs. American Journal of Veterinary Research. 66(1). 156–163. 17 indexed citations
12.
Banda, Nirmal K., Damian Kraus, Charles A. Dinarello, et al.. (2003). Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein. The Journal of Immunology. 170(4). 2100–2105. 128 indexed citations
13.
Banda, Nirmal K., et al.. (2003). Prevention of Collagen-Induced Arthritis in Mice Transgenic for the Complement Inhibitor Complement Receptor 1-Related Gene/Protein y. The Journal of Immunology. 171(4). 2109–2115. 25 indexed citations
14.
Kuiper, Sandra, Leo A. B. Joosten, Alison M. Bendele, et al.. (1998). DIFFERENT ROLES OF TUMOUR NECROSIS FACTOR α AND INTERLEUKIN 1 IN MURINE STREPTOCOCCAL CELL WALL ARTHRITIS. Cytokine. 10(9). 690–702. 114 indexed citations
15.
Bendele, Alison M., et al.. (1998). Effects of Interleukin-1 Receptor Antagonist in a Slow-Release Hylan Vehicle on Rat Type II Collagen Arthritis. Pharmaceutical Research. 15(10). 1557–1561. 25 indexed citations
16.
Bakker, Andrew C., Leo A. B. Joosten, Onno J. Arntz, et al.. (1997). Prevention of murine collagen‐induced arthritis in the knee and ipsilateral paw by local expression of human interleukin‐1 receptor antagonist protein in the knee. Arthritis & Rheumatism. 40(5). 893–900. 149 indexed citations
17.
Stengel, Peter W., Alison M. Bendele, Sandra L. Cockerham, & Steven A. Silbaugh. (1993). Inhaled A23187 Produces a Preferential Sensitization to Substance P. American Review of Respiratory Disease. 147(1). 196–201. 6 indexed citations
18.
Wong, W.S. Fred, et al.. (1992). Pharmacological and histological examinations of regional differences of guinea‐pig lung: a role of pleural surface smooth muscle in lung strip contraction. British Journal of Pharmacology. 105(3). 620–626. 11 indexed citations
19.
Hom, Joanne T., Harlan W. Cole, & Alison M. Bendele. (1990). Interleukin 1 enhances the development of spontaneous arthritis in mice. Clinical Immunology and Immunopathology. 55(1). 109–119. 23 indexed citations
20.
Butler, Larry, et al.. (1989). Interleukin 1-induced pathophysiology: Induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clinical Immunology and Immunopathology. 53(3). 400–421. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026